Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00111540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Study to Examine the Long Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This open label study is designed to assess long term glucose control, as measured by hemoglobin A1c (HbA1c) and to evaluate long term safety and tolerability in subjects with type 2 diabetes mellitus who receive subcutaneously injected exenatide administered twice a day.
Study identification
- NCT ID
- NCT00111540
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 456 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2002 (Type not available)
- Primary completion
- Sep 2006 (Actual)
- Completion
- Sep 2006 (Actual)
- Last update posted
- Feb 23, 2015
2002 – 2006
United States locations
- U.S. sites
- 60
- U.S. states
- 25
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Bellflower | California | — | — |
| Research Site | Burlingame | California | — | — |
| Research Site | Chula Vista | California | — | — |
| Research Site | Concord | California | — | — |
| Research Site | Encino | California | — | — |
| Research Site | Fremont | California | — | — |
| Research Site | La Jolla | California | — | — |
| Research Site | Los Gatos | California | — | — |
| Research Site | Moreno Valley | California | — | — |
| Research Site | Redwood City | California | — | — |
| Research Site | San Mateo | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | Aurora | Colorado | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Largo | Florida | — | — |
| Research Site | Maitland | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Blairsville | Georgia | — | — |
| Research Site | Honolulu | Hawaii | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Lexington | Kentucky | — | — |
| Research Site | Covington | Louisiana | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Slidell | Louisiana | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Edina | Minnesota | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Gulfport | Mississippi | — | — |
| Research Site | Picayune | Mississippi | — | — |
| Research Site | Chesterfield | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Cary | North Carolina | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Marion | Ohio | — | — |
| Research Site | Maumee | Ohio | — | — |
| Research Site | Mentor | Ohio | — | — |
| Research Site | Clinton | Oklahoma | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Medford | Oregon | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Camp Hill | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Midland | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Olympia | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00111540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2015 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00111540 live on ClinicalTrials.gov.